ACHC vs HSIC: fair value comparison
Acadia Healthcare Company, Inc. and Henry Schein, Inc. · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, HSIC currently sits closer to the top of our discount ranking.
| ACHC | HSIC | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $30.59 | $89.52 |
| 12-month range | $13.21–$31.25 | $63.20–$86.51 |
| Sector rank | #77 of 113 Healthcare | #72 of 113 Healthcare |
| Quality grade | F | F |
| Momentum grade | — | B |
| Leverage | Moderate | Moderate |
| Margin trend | Expanding | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Uptrend |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: ACHC fair value analysis · HSIC fair value analysis